Oklo Inc. (NYSE:OKLO) just proved it can build a nuclear reactor as fast as it promised. On August 6, the company announced its Groves Isotope Test Reactor in Lockhart, Texas, achieved first criticality, a controlled, self-sustaining nuclear chain reaction, less than a year after groundbreaking. It’s the first project under the US Department of Energy’s Reactor Pilot Program to reach criticality on private land from a greenfield site, and Oklo says it may be the fastest privately funded, privately sited reactor build in history.
Bull Case: Proof It Can Build What It Promises
CEO Jacob DeWitte called it “an incredible milestone for our team,” noting Oklo built Groves from raw land, handled the civil excavation and construction itself, and manufactured or procured every component, including fuel, in-house. On the company’s August 7 earnings call, management put the timeline at under 11 months from greenfield to criticality. Groves is meant to anchor Oklo’s isotope business, supplying materials for healthcare, industry, research, space, and national security, with revenue expected to begin in the first half of 2027 out of a commercial Idaho radiochemistry lab.
Management says the engineering practices, training programs, and commissioning experience from Groves should reduce execution risk across the company’s future isotope, powerhouse, and fuel cycle projects. The balance sheet backs that ambition, with $3 billion in cash and marketable securities on hand after Oklo raised $1.9 billion in 2026 through its at-the-market programs. The broader pipeline kept moving too, with Aurora-INL site excavation nearly complete and a Kiewit memorandum of understanding advancing the 1.2-gigawatt Ohio Power Campus that will supply Meta. Shares jumped more than 10% on August 7, the day after the update, coinciding with the earnings report.
Bear Case: The Bill That Comes With It
The milestone came alongside a bigger bill. Oklo reported a net loss of $81.6 million for the quarter, with an operating loss of $124.2 million, and the company still has no forward price-to-earnings ratio because it isn’t yet profitable. Management raised its 2026 operating cash flow guidance to $120 million to $150 million, up from $80 million to $100 million, and lifted capital expenditure guidance to $400 million to $500 million from $350 million to $450 million, both tied to accelerated procurement for Aurora-INL and opportunistic fuel purchases. Groves itself is also a test reactor for isotopes, not Oklo’s commercial power business. The Aurora-INL project that would validate the company’s powerhouse platform isn’t targeted to start up until 2028, and the first phase of the Aurora-Ohio powerhouse meant to supply Meta’s data centers isn’t expected until early 2030.
Market Sentiment
Oklo has no forward price-to-earnings ratio, a function of a company still posting operating losses rather than a signal on its own. Short interest sits at 2.89% of the float, real skepticism but not a crowded bearish trade. The hedge fund count tied to the stock held flat at 36 funds quarter-over-quarter, suggesting institutional positioning hasn’t shifted around this milestone. Together the numbers describe a stock where sentiment is steady, and valuation still rests on the company’s timeline rather than its earnings.
What Comes Next
Groves gives Oklo a genuine proof point: a reactor built from bare land to criticality in under a year, inside the Reactor Pilot Program’s compressed timeline. That execution, plus $3 billion in liquidity and a pipeline moving through Aurora-INL and the Ohio Power Campus, is what sent shares up more than 10% on August 7. But Groves produces isotopes, not electricity, and Oklo is still posting losses while its commercial power projects sit years away.
While we acknowledge the risk and potential of OKLO as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than OKLO and that has 10,000% upside potential, check out our report about this cheapest AI stock.
READ NEXT: 10 Best Future Stocks to Buy Under $10 and 12 Best Performing Semiconductor Stocks to Invest In.
Disclosure: None. Follow Insider Monkey on Google News.
Hedge Fund Resource Center